UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038079
Receipt number R000043399
Scientific Title System of 3-dimensional model of gastric cancer using endoscopic images
Date of disclosure of the study information 2019/09/22
Last modified on 2023/09/25 21:20:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

System of 3-dimensional model of gastric cancer using endoscopic images

Acronym

Three dimensional model of gastric cancer

Scientific Title

System of 3-dimensional model of gastric cancer using endoscopic images

Scientific Title:Acronym

Three dimensional model of gastric cancer

Region

Japan


Condition

Condition

Patients who have gastric cancer and undergo esophagogastroduodenoscopy(EGD)

Classification by specialty

Gastroenterology Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Developing the system of 3-dimensional model of gastric cancer using EGD images

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Developing the system of 3-dimensional model of gastric cancer using EGD images

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Esophagogastroduodenoscopy (EGD)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Patients with gastric cancer
2) Undergoing EGD under intravenous sedation
3) Aged 20-80 years
4) Written informed consent

Key exclusion criteria

1) Severe co-morbidities
2) A history of gastric surgery
3) Lack of informed consent

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Sho
Middle name
Last name Suzuki

Organization

Nihon University School of Medicine

Division name

Division of Gastroenterology and Hepatology, Department of Medicine

Zip code

101-8309

Address

Chiyoda-ku

TEL

0332931711

Email

s.sho.salubriter.mail@gmail.com


Public contact

Name of contact person

1st name Sho
Middle name
Last name Suzuki

Organization

Nihon University School of Medicine

Division name

Division of Gastroenterology and Hepatology, Department of Medicine

Zip code

101-8309

Address

Chiyoda-ku

TEL

0332931711

Homepage URL


Email

s.sho.salubriter.mail@gmail.com


Sponsor or person

Institute

Nihon University School of Medicine, Division of Gastroenterology and Hepatology, Department of Medicine,

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Nihon University Hospital

Address

1-6 Kanda-Surugadai, Chiyoda-ku, Tokyo, Japan

Tel

0332931711

Email

nuhosp.rinri@nihon-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

日本大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2019 Year 09 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 08 Month 14 Day

Date of IRB

2019 Year 09 Month 12 Day

Anticipated trial start date

2019 Year 10 Month 01 Day

Last follow-up date

2020 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 09 Month 22 Day

Last modified on

2023 Year 09 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043399